Enabling life science researchers to make groundbreaking discoveries
Exiqon combines leading-edge scientific expertise in gene expression with our proprietary LNA™ technology.
Our products, services and scientific staff enable life science researchers to make groundbreaking discoveries. Moreover, we are addressing the unmet need for a new approach to the diagnosis of cancer.
Announcement nr. 25/2008 Til OMX Den Nordiske Børs København Vedbæk, 15. maj 2008 Exiqon – Consortium of Exiqon, Rigshospitalet and The University of Copenhagen awarded DKK 14 million by Danish National Advanced technology Foundation
.gif){kind=small}
.gif){kind=small}
.gif){kind=small}
.gif){kind=small}
